Suppliers / Đạt vi Phú

Đạt vi Phú

Vietnam Updated 9 July 2026

Đạt vi Phú is an API and finished-dose manufacturer based in Vietnam.

0
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Thiocolchicoside DAV (Vietnam) 2
Alendronat DAV (Vietnam) 1
Clobetasol Propionate DAV (Vietnam) 1
Emtricitabine DAV (Vietnam) 1
Esomeprazole DAV (Vietnam) 1
Racecadotril DAV (Vietnam) 1
Tacrolimus DAV (Vietnam) 1

Also appears on these molecule pages

Racecadotril finished dose Thiocolchicoside finished dose Esomeprazole API Tacrolimus API Emtricitabine API Clobetasol API

Questions about Đạt vi Phú

What does Đạt vi Phú make?
7 molecules are on record against Đạt vi Phú, including Thiocolchicoside, Alendronat, Clobetasol Propionate and Emtricitabine. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Đạt vi Phú comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Danapha Pharmaceutical Joint Stock also in Vietnam Fremed Pharmaceutical Joint Stock also in Vietnam Hanoi Cpc1 Pharmaceutical Joint Stock also in Vietnam Imexpharm also in Vietnam Minh also in Vietnam

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability